Effects of pravastatin on obesity, diabetes, and adiponectin in diet-induced obese mice.
AuthorsAraki K, Masaki T, Katsuragi I, Kakuma T, Yoshimatsu H,
JournalObesity (Silver Spring)
PubMed ID19186331
The aim of this study was to investigate the in vivo effects of pravastatin on the development of obesity and diabetes in diet-induced obese (DIO) mice. We examined food intake, body-weight changes, visceral white adipose tissue (WAT) adiponectin and resistin levels, and energy metabolism. Treatment with 100 mg/kg/day pravastatin for ... More